For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...

A newly developed mRNA-based flu vaccine is almost 35 per cent more effective against the most common form of influenza, ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

In other words, it’s a personalized cancer vaccine. Early tests of these vaccines are extremely promising. But the federal ...

A claque of online anti-vaccine influencers and dissentient researchers are claiming that COVID-19 vaccines are causing an ...

Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...

The Senate Homeland Security Subcommittee held a powerful hearing, 'Voices of the Vaccine-Injured,' where victims of alleged ...